000 01177 a2200313 4500
005 20250514234013.0
264 0 _c20051130
008 200511s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD001506.pub2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWark, P A B
245 0 0 _aNebulised hypertonic saline for cystic fibrosis.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cJul 2005
300 _aCD001506 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aAdministration, Inhalation
650 0 4 _aControlled Clinical Trials as Topic
650 0 4 _aCystic Fibrosis
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMucociliary Clearance
650 0 4 _aNebulizers and Vaporizers
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSaline Solution, Hypertonic
_xadministration & dosage
700 1 _aMcDonald, V
700 1 _aJones, A P
773 0 _tThe Cochrane database of systematic reviews
_gno. 3
_gp. CD001506
856 4 0 _uhttps://doi.org/10.1002/14651858.CD001506.pub2
_zAvailable from publisher's website
999 _c15689214
_d15689214